Clinical Trial Update: A Study of LP-118 in Patients With Advanced Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of LP-118 in patients with solid tumors and Non-Hodgkin lymphoma has reached completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumor

Drugs mentioned

• LP-118

Snippet

Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Conditions: Solid Tumor, Lymphoma, Non-Hodgkin | Phase 1 | Status: COMPLETED